Alto Neuroscience (ANRO) Shareholder's Equity (2023 - 2026)
Alto Neuroscience (ANRO) Shareholder's Equity (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
502.95 Mn |
| 10 |
Alto Neuroscience |
643.06 Mn |
379.30 Mn |
- |
243.37 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
243.37 Mn |
| Dec 31, 2025 |
151.14 Mn |
| Sep 30, 2025 |
111.56 Mn |
| Jun 30, 2025 |
123.41 Mn |
| Mar 31, 2025 |
139.10 Mn |
| Dec 31, 2024 |
151.46 Mn |
| Sep 30, 2024 |
165.05 Mn |
| Jun 30, 2024 |
179.78 Mn |
| Mar 31, 2024 |
193.10 Mn |
| Dec 31, 2023 |
-71.67 Mn |
| Sep 30, 2023 |
-61.10 Mn |
| Jun 30, 2023 |
-52.60 Mn |
| Mar 31, 2023 |
-45.23 Mn |
